Skip to content

Comparison the Effect of Thymus Vulgaris and Purslane (Portulaca Oleracea) Ointment on the painintensity during cannulation

Comparison the Effect of Thymus Vulgaris and Purslane (Portulaca Oleracea) Ointment on the painintensity during cannulation

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181029041495N3
Enrollment
48
Registered
2019-08-06
Start date
2019-07-27
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group:In the intervention groups, the purslane group, the 5% purslane ointment, was rubbed 5 cm 21 minutes before needle insertion at the fistula site and covered with a t

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years and older At least 3 months history of hemodialysis Verbal, mental and visual disability No dependence on analgesic drugs No pain before cannulation No use of painkillers, Thymus Vulgaris and purslane 24 hours before hemodialysis No wound in the fistula area Lack of liver disorders, asthma, allergies and dermatitis No known allergies or allergies to Thymus Vulgaris and purslane No use alcohol and drugs No record of mental illness and hospitalization in a psychiatric hospital

Exclusion criteria

Exclusion criteria: Patient's unwillingness to continue research The day of any adverse drug reaction or reaction during the intervention Failure to perform successful cannulation at first attempt and need to repeat cannulation Death or migration of the patient

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: The first, second, third and fourth hemodialysis sessions. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ggholamian

Gonabad University of Medical Sciences

gholamian.ft@gmail.com+98 51 5722 3028

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026